HomeMRNS • NASDAQ
add
Marinus Pharmaceuticals Inc
Previous close
$1.30
Day range
$1.30 - $1.38
Year range
$1.11 - $11.26
Market cap
73.06M USD
Avg Volume
3.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 7.68M | -26.02% |
Operating expense | 40.91M | -2.11% |
Net income | -38.67M | -11.34% |
Net profit margin | -503.57 | -50.50% |
Earnings per share | -0.68 | -1.49% |
EBITDA | -34.62M | -10.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 113.25M | -43.15% |
Total assets | 137.35M | -39.44% |
Total liabilities | 153.78M | 8.50% |
Total equity | -16.43M | — |
Shares outstanding | 54.93M | — |
Price to book | -4.33 | — |
Return on assets | -58.10% | — |
Return on capital | -79.77% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -38.67M | -11.34% |
Cash from operations | -37.46M | 9.68% |
Cash from investing | 20.88M | 140.17% |
Cash from financing | 257.00K | 247.70% |
Net change in cash | -16.32M | 82.57% |
Free cash flow | -23.72M | 21.38% |
About
Founded
2003
Headquarters
Website
Employees
166